1. American Diabetes Association. Standards of Medical Care in Patients with Diabetes - 2010. Diabetes Care 33 (Suppl.1):S11-S61, 2010
2. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Management of Diabetes Mellitus. Endocrine Practice 13(Suppl.1):3-68, 2007
3. Engelgau MM, Narayan KMV, Herman, WH. Screening for type 2 diabetes. Diabetes Care 23:1563-1580, 2000
4. American Diabetes Association.  Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 32 (Suppl.1):S62-S67, 2009
5. The International Expert Committee.  International Expert Committee Report on the role of the A1c assay in the diagnosis of diabetes.  Diabetes Care 32:1327-1334, 2009. 
6. The DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: Comparison of fasting and 2-hour diagnostic criteria. Arch Int Med 161:397-405, 2001
7. Harris TJ, Cook DG, Wicks PD, Cappuccio FP. Impact of the new American Diabetes Association and World Health Organization diagnostic criteria for diabetes on subjects from three ethnic groups living in the UK. Nutr Metab Cardiovasc Dis 10:305-309, 2000
8. Sievenpiper JL, Jenkins DJA, Josse RG, Vuksan V. Dilution of the 75-g oral glucose tolerance test improves overall tolerability but not reproducibility in subjects with different body compositions. Diab Res Clin Pract 51:87-95, 2001
9. Metzger BE, Coustan DR (eds): Proceedings of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 21(Suppl.2):B1-B167, 1998.
10. American Diabetes Association.  Gestational Diabetes Mellitus.  Diabetes Care 27 (Suppl. 1): S88-90, 2004.
11. Danilenko-Dixon DR, Van Winter JT, Nelson RL, Ogburn PL Jr. Universal versus selective gestational diabetes screening: application of 1997 American Diabetes Association recommendations. Am J Obstet Gynecol 181:798-802, 1999.
12. Crowe SM, Mastrobattista JM, Monga M. Oral glucose tolerance test and the preparatory diet. Am J Obstet Gynecol 182:1052-1054, 2000
13. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
14. Atilano LC, Lee-Parritz A, Lieberman E, Cohen AP, Barbieri RL. Alternative methods of diagnosing gestational diabetes mellitus. Am J Obstet Gynecol, 181:1158-1161, 1999
15. Lavin JP Jr, Lavin B, O"Donnell N. A comparison of costs associated with screening for gestational diabetes with two-tiered and one-tiered testing protocols. Am J Obstet Gynecol 184:363-367, 2001
16. Schmidt MI, Duncan BB, Reichelt AJ, Branchtein L, Matos MC, Costa e Forti A, Spichler ER, Pousada JMDC, Teixeira MM, Yamashita T for the Brazilian Gestational Diabetes Study Group. Diabetes Care 24:1151-1155, 2001
17. Chase HP, Cuthbertson DD, Dolan LM, Kaufman F, Krischer JP, Schatz DA, White NH, Wilson DM, Wolfsdorf J. The Diabetes Prevention Trial-Type 1 Study Group. First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes. J Pediatr 138:2244-249, 2001
18. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
19.  Bingley PJ, Bonifacio E, Mueller PW and Participating Laboratories.  Diabetes antibody standardization program:  first assay proficiency evaluation.  Diabetes 52:1128-1136, 2003.
20. Little RR, Rohlfing CL, Wiedmeyer H-M, Myers GL, Sacks DB, Goldstein DE for the NGSP Steering Committee. The National Glycohemoglobin Standardization Program: A five-year progress report. Clin Chem 47:1985-1992, 2001.
21.  Consensus committee.  Consensus statement on the worldwide standardization of the HbA1c measurement.  Diabetes Care 30:2399-2400, 2007;  Diabetologia 50:2042-2043, 2007.
22. United Kingdom Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
23. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study. Diabetes Res Clin Prac 28:103-117, 1995.
24. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. Translating the A1C Assay into Estimated Average Glucose Values. Diabetes Care 31: 1-6, 2008.
25. Diabetes Research in Children Network (DirectNet) Study Group.  Relationship of A1C to glucose concentrations in children with type 1 diabetes: Assessments by high-frequency glucose determinations by sensors. Diabetes Care 31:381-385, 2008.
26. Weykamp C, John WG, Mosca A, Hoshino T, Little R, Jeppsson J-O, Goodall I, Miedema K, Myers G, Reinauer H, Sacks, DB, Slingerland R, Siebelder C. The IFCC reference measurement system for HbA1c: a 6-year progress report. Clin Chem 54:240-248, 2008.
27. American Diabetes Association.  Tests of glycemia in diabetes.  Diabetes Care 27 (Suppl. 1): S91-S93, 2004.
28. Whipple AE: The surgical therapy of hyperinsulinism. J Int Chir 3:237-276, 1938
29. Marks V: Recognition and differential diagnosis of spontaneous hypoglycaemia.
Clin Endocrinol 37:309, 1992
30. Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, Savice FJ. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline.  J Clin Endocrinol Metab 94:709-728, 2009.
31. Service FJ: Hypoglycemic disorders. N Engl J Med 332:1144-1152, 1995
32. Hirshberg B, Livi A, Bartlett DL, et al: Forty-eight-hour fast: the diagnostic test fornsulinoma. J Clin Endocrinol Metab 85:3222-3226, 2000
33. Service FJ, Natt N: Clinical perspective: the prolonged fast. J Clin Endocrinol
Metab 85:3973-3974, 2000
34. Kumar D, Mehtalia SD, Miller LV: Diagnostic use of glucagon-induced insulin
response. Studies in patients with insulinoma or other hypoglycemic conditions.
Ann Int Med 80:697-701, 1974
35. Hoff AO, Vassilopoulou-Sellin R: The role of glucagon administration in the
diagnosis and treatment of patients with tumor hypoglycemia. Cancer 82:1585-1592, 1998
36. Marks V, Samols E: Glucagon test for insulinoma: a chemical study in 25 cases. J
Clin Path 21:346-352, 1968
37. Service FJ, O'Brien PC, Kao PC, Young Jr WF: C-peptide suppression test: Effects
of gender, age and body mass index: Implications for the diagnosis of insulinoma. J Clin Endocrinol Metab 74:204-210, 1992